Navigation path

Policy areas
Who is in charge?
Competition and you
In this section:
What's new?
Cases >
ECN Pharma Report
Sector inquiry
Life cycles in pharma

Report on Competition enforcement in the pharmaceutical sector (2009-2017)

On 28 January 2019, the European Commission adopted the Report ‘European competition authorities working together for affordable and innovative medicines’ on competition enforcement in the pharmaceutical sector.

The Report has been drafted in close cooperation with the national competition authorities of the EU Member States, which, together with the Commission, make up the European Competition Network (ECN).

The Report covers the period 2009-2017. It describes how intervening against anti-competitive practices by companies and preventing harmful mergers complements the efforts by other stakeholders (e.g. in regulation) to improve access to affordable and innovative medicines for patients in Europe.

The Report provides

  • an overview of competition law enforcement by the Commission and the national competition authorities in the pharmaceutical sector (Chapter 2);
  • a description of key characteristics of the sector that shape the competition assessment (Chapter 3); and
  • an illustration, including through practical examples, of how competition law enforcement contributes to more competitive prices of medicines (Chapter 4) and to innovation and choice in medicines and treatments (Chapter 5).

Executive summary